Stoke Therapeutics (STOK) PT Raised to $60 at Canaccord
Tweet Send to a Friend
(Updated - March 20, 2026 6:58 AM EDT)
Canaccord analyst Sumant Kulkami raised the price target on Stoke Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord analyst Sumant Kulkami raised the price target on Stoke Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


